Sep 032020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA –  Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the appointment of Dr. Camille Bedrosian, M.D. to its board of directors as an independent member. Dr. Bedrosian ...

Crinetics Pharmaceuticals appoints Dr Camille Bedrosian to its Board as Independent Director

Crinetics Pharmaceuticals appoints Dr Camille Bedrosian to its Board as Independent Director

From:: Crinetics Pharmaceuticals appoints Dr Camille Bedrosian to its Board as Independent Director

Sorry, the comment form is closed at this time.